NFH
ACAD icon

NEXT Financial Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

NEXT Financial Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$215K Buy
+8,000
New +$187K 0.05% 342

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

NEXT Financial Holdings's ACAD Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Acadia Pharmaceuticals (ACAD) in Q1 2019: 8,000 shares worth $215K. The stake represents 0.05% of the portfolio and ranks #342 among its holdings.

199 funds tracked by Wall St. Rank hold ACAD as of Q1 2019.

  • NEXT Financial Holdings held 8,000 shares of Acadia Pharmaceuticals worth $215K as of Q1 2019.
  • Acadia Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
  • Acadia Pharmaceuticals made up 0.05% of NEXT Financial Holdings's portfolio in Q1 2019, its #342 holding.
  • 199 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.